Carlo
PeopleProgramsSpecialtiesInstitutionsPricing
Sign inJoin waitlistJoin the waitlist
Carlo

the ai that helps you match

Part of the Carlo family
© 2026 Carlo Finance, Inc.
PeopleProgramsSpecialtiesInstitutionsPricingMethodologyPrivacyTerms
Back to overview

Keck School of Medicine of USC Neurology

Residency · Los Angeles, CA

Sponsored by Keck School of Medicine of USC · Director Katherine Wong

Research

Works by its people
3,348
Authors
69
First-author works
783
Citations
258,534
20112026

Topics

  • Dementia and Cognitive Impairment Research 425
  • Acute Ischemic Stroke Management 298
  • Alzheimer's disease research and treatments 245
  • Multiple Sclerosis Research Studies 124
  • Parkinson's Disease Mechanisms and Treatments 98
  • Neurological disorders and treatments 76
  • Down syndrome and intellectual disability research 67
  • Intracerebral and Subarachnoid Hemorrhage Research 59
  • HIV Research and Treatment 57
  • Botulinum Toxin and Related Neurological Disorders 54
  • Intracranial Aneurysms: Treatment and Complications 51
  • Meningioma and schwannoma management 40

Most cited

  1. Lecanemab in Early Alzheimer's Disease.

    The New England journal of medicine · 2023 · 4,522 citations · Paul Aisen

  2. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup.

    Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024 · 2,230 citations · Michael Rafii

  3. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.

    Stroke · 2021 · 2,510 citations · Amytis Towfighi

  4. The Amyloid-β Pathway in Alzheimer's Disease.

    Molecular psychiatry · 2021 · 1,588 citations · Paul Aisen

  5. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.

    The Lancet. Neurology · 2025 · 326 citations · Lilyana Amezcua

  6. Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease.

    The journal of prevention of Alzheimer's disease · 2022 · 1,162 citations · Paul Aisen

  7. Lecanemab: Appropriate Use Recommendations.

    The journal of prevention of Alzheimer's disease · 2023 · 755 citations · Paul Aisen

  8. Donanemab: Appropriate use recommendations.

    The journal of prevention of Alzheimer's disease · 2025 · 180 citations · Paul Aisen